40340-41-8Relevant articles and documents
Simple one-pot synthesis of 5-(chloromethyl)isoxazoles from aldoximes and 2,3-dichloro-1-propene
Kondrashov, Evgeniy V.,Shatokhina, Nina S.
, p. 1228 - 1232 (2020/01/08)
[Figure not available: see fulltext.] A one-pot synthesis of 3-substituted 5-chloromethylisoxazoles from available starting aldoximes and 2,3-dichloro-1-propene, serving both as a solvent and reagent, is proposed. Excess 2,3-dichloro-1-propene is recovered after the reaction. The synthesis is effective for oximes of both aromatic and aliphatic aldehydes.
Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents
Li, Wen-Tai,Hwang, Der-Ren,Chen, Ching-Ping,Shen, Chien-Wei,Huang, Chen-Long,Chen, Tung-Wei,Lin, Chi-Hung,Chang, Yee-Ling,Chang, Ying-Ying,Lo, Yue-Kan,Tseng, Huan-Yi,Lin, Chu-Chung,Song, Jeng-Shin,Chen, Hua-Chien,Chen, Shu-Jen,Wu, Se-Hui,Chen, Chiung-Tong
, p. 1706 - 1715 (2007/10/03)
A series of N-heterocyclic indolyl glyoxylamides were synthesized and evaluated for in vitro and in vivo anticancer activities. They exhibited a broad spectrum of anticancer activity not only in murine leukemic cancer cells but also in human gastric, breast, and uterus cancer cells as well as their multidrug resistant sublines with a wide range of IC50 values. They also induced apoptosis and caused DNA fragmentation in human gastric cancer cells. Among the compounds studied, 7 showed the most potent activity of growth inhibition (IC50 17-1711 nM) in several human cancer cells. Given orally, compounds 7 and 13 dose-dependently prolonged the survival of animals inoculated with P388 leukemic cancer cells. N-Heterocyclic indolyl glyoxylamides may be useful as orally active chemotherapeutic agents against cancer and refractory cancerous diseases of multidrug resistance phenotype.
Extractant for selectively extracting strontium from aqueous solution containing the same
-
, (2008/06/13)
An extractant for selectively extracting strontium from an aqueous solution containing the same, which comprises a 1,2-benzenebis(1,4-dioxanonyl-6,8-dionato)metal complex of the following structural formula: STR1 wherein M represents a metal ion of Cu (II), Zn (II) or Ni (II).